RIKER LAUREN
Senior Vice President, Finance
RIKER LAUREN has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 13, 2026.
On the most recent filing, RIKER LAUREN is listed as Senior Vice President, Finance at Pacira BioSciences, Inc. Inside the rolling window, RIKER LAUREN reported no open-market purchases and 3 open-market sales totaling $261K in PCRX. The largest disclosed transaction in the window is a sale of 6,115 PCRX shares on Jun 11, 2026, worth $144K.
Companies traded
Other insiders at PCRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$261K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has RIKER LAUREN made?
RIKER LAUREN has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does RIKER LAUREN trade?
RIKER LAUREN has filed SEC Form 4 disclosures for 1 company, including PCRX.
When was RIKER LAUREN's most recent SEC Form 4 filing?
RIKER LAUREN's most recent SEC Form 4 filing on Tracefour is dated Jun 13, 2026.
What is RIKER LAUREN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, RIKER LAUREN is listed as Senior Vice President, Finance.
What is RIKER LAUREN's total buy and sell value in the current window?
Inside the rolling retention window, RIKER LAUREN bought $0 and sold $261K based on SEC Form 4 filings.
What was RIKER LAUREN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,115 PCRX shares on 2026-06-11, worth $144K, per SEC Form 4 filings.